Healthcare provider perceptions and reported practices regarding opioid prescription for patients with chronic cancer pain.

Healthcare provider perceptions and reported practices regarding opioid prescription for patients with chronic cancer pain.

Publication date: Jan 22, 2024

Data indicates that clinicians might be under-prescribing opioids for patients with chronic cancer pain, and this could impact adequate pain management. Few studies have sought to understand healthcare provider (HCP) perceptions and practices regarding the prescription of opioids for chronic cancer pain. We assessed HCP perceptions and practices regarding opioid prescription for patients with chronic cancer pain since the onset of the COVID-19 pandemic. An anonymous cross-sectional survey was conducted among 186 HCPs who attended an opioid educational event in April 2021 and 2022. Sixty-one out of 143 (44%) opioid prescribers reported reluctance to prescribe opioids for chronic cancer pain. In a multivariate logistic model, younger participants (log OR - 0. 04, 95% CI - 0. 085, - 0. 004; p = 0. 033) and pain medicine clinicians (log OR - 1. 89, CI - 3. 931, - 0. 286; p = 0. 034) were less reluctant, whereas providers who worry about non-medical opioid use were more reluctant to prescribe opioids (log OR 1. 58 95% CI 0. 77-2. 43; p 

Concepts Keywords
Clinicians Chronic cancer pain
Opioids Nonmedical
Pandemic Opioid
Prescribing

Semantics

Type Source Name
disease MESH cancer
disease MESH COVID-19 pandemic

Original Article

(Visited 1 times, 1 visits today)